| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |